Median Technologies

ALMDT

Company Profile

  • Business description

    Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The company focuses on the oncology clinical trials market and the cancer patient care market. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer. Its revenue is generated from contracts for providing imaging services for oncology clinical trials using dedicated software. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.

  • Contact

    1800 Route Des Cretes
    Les Deux Arcs, Building B
    Valbonne06560
    FRA

    T: +33 493333777

    https://www.mediantechnologies.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    134

Stocks News & Analysis

stocks

Undervalued tech share oversold on AI fears

Has the market overlooked this ASX tech share?
stocks

Margins have bottomed for ASX listed consumer goods company

Impact of tariffs have been priced in.
stocks

SpaceX rally continues, expanding sky-high valuations

SpaceX has risen 50% from its IPO price to become the second-most-expensive stock under Morningstar’s coverage.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,031.209.400.10%
CAC 408,381.6339.51-0.47%
DAX 4025,016.9931.170.12%
Dow JONES (US)51,564.7072.150.14%
FTSE 10010,420.2857.010.55%
HKSE23,768.52156.29-0.65%
NASDAQ26,517.93496.281.91%
Nikkei 22572,353.961,103.901.55%
NZX 50 Index13,446.0549.58-0.37%
S&P 5007,500.580.000.00%
S&P/ASX 2008,816.1014.200.16%
SSE Composite Index4,163.1072.621.78%

Market Movers